Atezolizumab-Induced Bell's Palsy in a Patient With Small Cell Lung Cancer

• Main Authors: Asim Kichloo MD (Author), Michael Stanley Albosta MD (Author), Shakeel M. Jamal MD (Author), Michael Aljadah MD (Author), Farah Wani MD (Author), Insija Selene MD (Author), Jagmeet Singh MD (Author), Asma Taj MD (Author)
• Format: Book
• Published: SAGE Publishing, 2020-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immune checkpoint inhibitors are rapidly becoming popular therapeutic options for patients suffering from a number of malignancies. Atezolizumab is a programmed cell death ligand-1 inhibitor, and binding to this ligand decreases the ability of tumor cells to evade the immune system, resulting in sel...